Daily FNArena News

Aristocrat Leisure’s eyes remain on the i-Gaming prize, as the company continues its pursuit of growth in the US market despite an economic downturn

Tim Boreham digs deep into the evolving world of cancer diagnostics, highlighting the newly named Inoviq Ltd

Despite strong year-on-year sales growth in the new financial year, brokers remain split on how an inflationary environment may impact Metcash’s market share in the coming year

New research on Imdex points to a company in transition with less exposure to cyclical downturns for junior miners and exploration budgets

S&P conducted a webinar this week on inflation and the outlook for Australian sectors and companies, and FNArena provides a round-up of the agency’s observations.

ALS Ltd has a bold plan to reduce its exposure to traditional commodity price cyclicality, which brokers believe is achievable in the longer term

Ahead of the Herd’s Rick Mills explains how/why high energy prices and global food inflation are two twins connected at the hip

Mineral Resources is considering a spin-off of its lithium business to a US listing, which brokers agree would unlock significant trapped value

Michael Gable of Fairmont Equities notes price action suggests CSL is a buying opportunity, and more so on a breakout

Brokers remain upbeat on the outlook for Ansarada Group following FY22 results, despite a softer near-term outlook